Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CDKN2A overexpression
i
Other names:
CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1029
Related biomarkers:
Expression
Mutation
CNA
Others
‹
CDKN2A promoter methylation (2)
ALK rearrangement + CDKN2A deletion (1)
BAP1 mutation + IDH2 R172W + CDKN2A deletion + CDKN2B deletion (1)
BRAF V600E + CDKN2A deletion + MYCN amplification (1)
BRAF V600E + CDKN2A deletion + RB1 expression (1)
BRAF V600K + CDKN2A deletion + RB1 expression (1)
CDKN2A Negative + NRAS Mutation (1)
CDKN2A deletion + CDKN2B deletion + MTAP deletion + TERT mutation (1)
CDKN2A mutation + PD-L1 overexpression (1)
CDKN2A mutation + TMB-H (1)
EGFR mutation + CCND1 expression + CDKN2A deletion (1)
NF1 mutation + CDKN2A deletion + CDKN2B deletion + MTAP deletion (1)
TMB-L + ARID1A deletion + CDKN2A deletion + CDKN2B deletion + MTAP deletion + PIK3R1 N564D + NBN P81fs*23 (1)
CDKN2A promoter methylation (2)
ALK rearrangement + CDKN2A deletion (1)
BAP1 mutation + IDH2 R172W + CDKN2A deletion + CDKN2B deletion (1)
BRAF V600E + CDKN2A deletion + MYCN amplification (1)
BRAF V600E + CDKN2A deletion + RB1 expression (1)
BRAF V600K + CDKN2A deletion + RB1 expression (1)
CDKN2A Negative + NRAS Mutation (1)
CDKN2A deletion + CDKN2B deletion + MTAP deletion + TERT mutation (1)
CDKN2A mutation + PD-L1 overexpression (1)
CDKN2A mutation + TMB-H (1)
EGFR mutation + CCND1 expression + CDKN2A deletion (1)
NF1 mutation + CDKN2A deletion + CDKN2B deletion + MTAP deletion (1)
TMB-L + ARID1A deletion + CDKN2A deletion + CDKN2B deletion + MTAP deletion + PIK3R1 N564D + NBN P81fs*23 (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CDKN2A overexpression
Soft Tissue Sarcoma
CDKN2A overexpression
Soft Tissue Sarcoma
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
CDKN2A overexpression
Ovarian Cancer
CDKN2A overexpression
Ovarian Cancer
palbociclib
Sensitive: D – Preclinical
palbociclib
Sensitive
:
D
palbociclib
Sensitive: D – Preclinical
palbociclib
Sensitive
:
D
CDKN2A overexpression
Mantle Cell Lymphoma
CDKN2A overexpression
Mantle Cell Lymphoma
venetoclax
Sensitive: D – Preclinical
venetoclax
Sensitive
:
D
venetoclax
Sensitive: D – Preclinical
venetoclax
Sensitive
:
D
CDKN2A overexpression
Estrogen Receptor Positive Breast Cancer
CDKN2A overexpression
Estrogen Receptor Positive Breast Cancer
CDK4 inhibitor + CDK6 inhibitor
Resistant: D – Preclinical
CDK4 inhibitor + CDK6 inhibitor
Resistant
:
D
CDK4 inhibitor + CDK6 inhibitor
Resistant: D – Preclinical
CDK4 inhibitor + CDK6 inhibitor
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login